Vaccine News and Research

Latest Vaccine News and Research

Despite one year without polio cases, threat of disease still looms in India

T. Jacob John, a former professor of clinical virology an the Christian Medical College in Vellore, India, who has served on several Global and National Committees on Immunization and Polio Eradication, writes in this opinion piece in India's Hindu, "While one year has passed without polio caused by natural poliovirus, we can claim complete eradication only after we ensure the absence of wild and vaccine polioviruses in the population."

13 Jan 2012

Al Jazeera examines candidate malaria vaccine, other ongoing efforts to thwart the disease

Al Jazeera reports on the candidate malaria vaccine known as RTS,S, which "has been heralded as one of the Top 10 Scientific Breakthroughs of 2011 by Time and Science magazines, Doctors Without Borders and the Lancet."

13 Jan 2012

Cryo-electron microscopy can visualize structures within viruses

Since the discovery of the microscope, scientists have tried to visualize smaller and smaller structures to provide insights into the inner workings of human cells, bacteria and viruses. Now, researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, have developed a new way to see structures within viruses that were not clearly seen before.

13 Jan 2012

Non-toxin vaccine shows promise against lethal anthrax infection

Vaccination with the anthrax capsule-a naturally occurring component of the bacterium that causes the disease-protected monkeys from lethal anthrax infection, according to U.S. Army scientists. The study, which appears in the Jan. 20th print edition of the journal VACCINE, represents the first successful use of a non-toxin vaccine to protect monkeys from the disease.

13 Jan 2012

India marking health achievement in polio-free year but cautious optimism remains among some experts

"On Friday, India marks a huge public health milestone -- a year since a case of polio was found in the country -- a critical step in being declared polio-free and an achievement that many experts long argued was impossible," the Globe and Mail reports.

13 Jan 2012

ISU receives U.S. patent for phytol-derived adjuvant

While conducting research on cancer, Swapan Ghosh and a team of graduate and doctoral students discovered a phytol-derived adjuvant. That adjuvant formula just became U.S. Patent No. 8,088,395.

13 Jan 2012

Tips to optimize your health care budget this year

You can help lower your out-of-pocket health care costs by understanding what your health plan covers, what it does not cover and how to make the most of every dollar spent on health care and health insurance.

13 Jan 2012

International health groups ally to fight cholera in Haiti; Officials emphasize need for sanitation infrastructure

"Unless steps are taken to eliminate cholera from Haiti and the neighboring Dominican Republic, the disease will likely resurge and could even spread to other parts of the Caribbean, international health officials said Wednesday," CQ HealthBeat reports.

13 Jan 2012

Office-based medical practice can promote vaccination in adults

Promoting immunizations as a part of routine office-based medical practice is needed to improve adult vaccination rates, a highly effective way to curb the spread of diseases across communities, prevent needless illness and deaths, and lower health care costs, according to a new RAND Corporation study.

12 Jan 2012

END7 campaign aims to combat seven major NTDs by 2020

Launched today, the END7 campaign is dedicated to eliminating seven major neglected tropical diseases (NTDs) as a public health threat to poor communities by the end of 2020.

10 Jan 2012

Telormedix raises 7.5 million CHF

Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and inflammatory diseases, today announced that it has raised 7.5 Million CHF from existing investors Aravis Venture and Proquest Investments.

10 Jan 2012

Nigerian leaders sign onto Gates immunization challenge

"Nigeria's 36 Executive Governors and the Federal Capital Territory have signed up to the Nigeria Immunization Challenge launched by the Bill & Melinda Gates Foundation last year," a Gates Foundation press release states.

10 Jan 2012

CNBG, Aeras reach final agreement to develop new TB vaccines

The global fight against the tuberculosis epidemic receives a boost today as Aeras and the China National Biotec Group (CNBG) announce that they have reached final agreement to jointly develop new tuberculosis (TB) vaccines.

10 Jan 2012

Blacklisted British doctor sues journal

A British doctor who lost his medical license in the U.K. in 2010 and who was accused in a journal last year of publishing bogus research filed a defamation suit this week in state District Court in Travis County.

9 Jan 2012

Merck selects Idera Pharmaceuticals' TLR agonists for evaluation, use as vaccine adjuvant candidates

Idera Pharmaceuticals, Inc. today announced that Merck, known as MSD outside the United States and Canada, has selected several novel Toll-like Receptor agonists targeted to TLR7, TLR8 or TLR9 for evaluation and use as vaccine adjuvant candidates under the companies' collaboration and license agreement.

9 Jan 2012

Enrollment complete in Diamyd Phase II study for type 1 diabetes

A total of 50 children aged four and older with a high risk of developing type 1 diabetes have been enrolled in a researcher-initiated Phase II study, DiAPREV-IT, with Diamyd Medical's diabetes vaccine Diamyd. The study is thus fully recruited.

9 Jan 2012

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

Colby Pharmaceutical Company (CPC) today announced publication of new results showing that a single dose of JVRS-100 adjuvanted H5N1 influenza vaccine enhanced-immune responses, -dose sparing, and -cross-clade influenza virus protection.

9 Jan 2012

MPIIB, QIAGEN partner to develop latent TB diagnostic test

QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime.

From QIAGEN Manchester Limited 9 Jan 2012

Positive results from BioCryst's BCX4208 Phase 2b study on gout

BioCryst Pharmaceuticals, Inc. announced long-term results from the extension phase of its randomized Phase 2b study of BCX4208 added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone.

8 Jan 2012

Bristol-Myers Squibb signs definitive agreement to acquire Inhibitex

Bristol-Myers Squibb Company and Inhibitex, Inc. announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire Inhibitex for $26.00 per share in cash pursuant to a cash tender offer and second step merger.

8 Jan 2012